119 related articles for article (PubMed ID: 24322885)
1. Novel use of a Dektak 150 surface profiler unmasks differences in resorption pit profiles between control and Charcot patient osteoclasts.
Petrova NL; Petrov PK; Edmonds ME; Shanahan CM
Calcif Tissue Int; 2014 Apr; 94(4):403-11. PubMed ID: 24322885
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TNF-α Reverses the Pathological Resorption Pit Profile of Osteoclasts from Patients with Acute Charcot Osteoarthropathy.
Petrova NL; Petrov PK; Edmonds ME; Shanahan CM
J Diabetes Res; 2015; 2015():917945. PubMed ID: 26137498
[TBL] [Abstract][Full Text] [Related]
3. Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand.
Mabilleau G; Petrova NL; Edmonds ME; Sabokbar A
Diabetologia; 2008 Jun; 51(6):1035-40. PubMed ID: 18389210
[TBL] [Abstract][Full Text] [Related]
4. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
Chai L; Zhou K; Wang S; Zhang H; Fan N; Li J; Tan X; Hu L; Fan X
Cell Physiol Biochem; 2018; 48(5):2123-2133. PubMed ID: 30110702
[TBL] [Abstract][Full Text] [Related]
5. Formation of osteoclasts on calcium phosphate bone cements and polystyrene depends on monocyte isolation conditions.
Bernhardt A; Schumacher M; Gelinsky M
Tissue Eng Part C Methods; 2015 Feb; 21(2):160-70. PubMed ID: 24919531
[TBL] [Abstract][Full Text] [Related]
6. Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor.
Tjoa ST; de Vries TJ; Schoenmaker T; Kelder A; Loos BG; Everts V
J Clin Periodontol; 2008 Jul; 35(7):568-75. PubMed ID: 18435789
[TBL] [Abstract][Full Text] [Related]
7. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
8. Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia.
Olivier BJ; Schoenmaker T; Mebius RE; Everts V; Mulder CJ; van Nieuwkerk KM; de Vries TJ; van der Merwe SW
Hepatology; 2008 Jan; 47(1):259-67. PubMed ID: 18022900
[TBL] [Abstract][Full Text] [Related]
9. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
10. Influence of receptor activator of nuclear factor (NF)-kappaB ligand (RANKL), macrophage-colony stimulating factor (M-CSF) and fetal calf serum on human osteoclast formation and activity.
Kreja L; Liedert A; Schmidt C; Claes L; Ignatius A
J Mol Histol; 2007 Aug; 38(4):341-5. PubMed ID: 17576525
[TBL] [Abstract][Full Text] [Related]
11. [Effect of lipopolysaccharide on osteoclasts formation and bone resorption function and its mechanism].
Zeng L; Xu Y; Xing G
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 May; 32(5):568-574. PubMed ID: 29806344
[TBL] [Abstract][Full Text] [Related]
12. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
13. Effects of vascular endothelial growth factor-C and -D on osteoclast differentiation and function in human peripheral blood mononuclear cells.
Motokawa M; Tsuka N; Kaku M; Kawata T; Fujita T; Ohtani J; Matsuda Y; Terao A; Tanne K
Arch Oral Biol; 2013 Jan; 58(1):35-41. PubMed ID: 22771550
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Neale SD; Smith R; Wass JA; Athanasou NA
Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
[TBL] [Abstract][Full Text] [Related]
16. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
Hirayama T; Danks L; Sabokbar A; Athanasou NA
Rheumatology (Oxford); 2002 Nov; 41(11):1232-9. PubMed ID: 12421995
[TBL] [Abstract][Full Text] [Related]
17. Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes.
Shinoda K; Sugiyama E; Taki H; Harada S; Mino T; Maruyama M; Kobayashi M
Bone; 2003 Oct; 33(4):711-20. PubMed ID: 14555277
[TBL] [Abstract][Full Text] [Related]
18. Characterization of two types of osteoclasts from human peripheral blood monocytes.
Yuasa K; Mori K; Ishikawa H; Sudo A; Uchida A; Ito Y
Biochem Biophys Res Commun; 2007 May; 356(2):354-60. PubMed ID: 17368425
[TBL] [Abstract][Full Text] [Related]
19. Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay.
Husheem M; Nyman JK; Vääräniemi J; Vaananen HK; Hentunen TA
Calcif Tissue Int; 2005 Mar; 76(3):222-30. PubMed ID: 15692727
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood mononuclear phagocytes from patients with chronic periodontitis are primed for osteoclast formation.
Herrera BS; Bastos AS; Coimbra LS; Teixeira SA; Rossa C; Van Dyke TE; Muscara MN; Spolidorio LC
J Periodontol; 2014 Apr; 85(4):e72-81. PubMed ID: 24059638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
